E-DRUG: Oseltamivir's adverse reactions
-----------------------------------------------------------------------
Dear e-druggers,
In spite of increasing stockpiling of oseltamivir world wide including developing countries, increasing evidences linked to central nervous system suppressing action of oseltamivir is accumulating: see my paper on IJRSM: (available at: http://npojip.org/sokuho/published-paperJRS431.pdf )
Japanese Pharmaceutical Affairs and Food Sanitation Council was scheduled to hold a session on Friday (8th August) to lift a ban on the use of Tamiflu by teens. Surprising enough, the Ministry of Health, Labor and Welfare (MHLW) announced on 5th August it will review its opinion about causality issues, as errors in the processing of data of an epidemiological study had been identified ( www.yomiuri.co.jp/dy/national/20080807TDY03302.htm )
I wrote a letter to the editor of BMJ on (Serious misclassification in Japanese MHLW epidemiologic study on Oseltamivir ( www.bmj.com/cgi/eletters/335/7610/59#200482 ) as a response to my own letter last year "Oseltamivir's adverse reactions: Fifty sudden deaths may be related to central suppression" ( www.bmj.com/cgi/content/full/335/7610/59 ).
It is not a sort of simple errors in the processing of data, but the fundamental and serious error that reverses the fact and misleads people.
Please look at above.
Kusuri-no-check
ISDB-full-membership Drug Bulletin:
"Check-up Your Pills to Save Your Life"
Rokuro Hama